The Investment Committee give you their top stocks to watch for the second half.

One notable example is the partnership with Zai Lab to develop and commercialize povetacicept in mainland China, Hong Kong, Macau, Taiwan, and Singapore. This collaboration provides Vertex with ...

U.S. stock futures rose on Monday following Friday's sharp fall as investors digest tariff updates and earnings reports.

Pleas note: we will be discontinuing the Global Markets Report after 28 February. Australian shares are set to open lower, ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

What's so special about Jan. 30 for Vertex? It's the PDUFA action date set by the U.S. Food and Drug Administration (FDA) for making an approval decision on suzetrigine in treating acute pain.

Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2024, and provided ...

In December, Vertex's CASGEVY gained regulatory approval in the UAE for sickle cell disease and transfusion-dependent beta-thalassemia. Suzetrigine for moderate-to-severe acute pain awaits an FDA ...

Launched by homegrown real estate portal MOGUL.sg, MAIA is a virtual property assistant designed to streamline property ...